Current Advance in Targeted Treatment and Immunotherapy for BRAF-mutant Advanced Non-small Cell Lung Cancer
This article reviewed the progress of immunological and targeted therapy for patients with BRAF-mutated NSCLC.
DOI: 10.3779/j.issn.1009-3419.2021.101.29
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | China Health | Genetics | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer